Tam Ly
Infectious Disease · Warrenton, VANPI 1992858443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Viiv Healthcare Company at 26.8% of the total. Reporting peaked in 2021 at $553 and has fallen 88.2% since, to $65 in 2023.
Across 92 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$489
- Smith+Nephew$196
- Gilead$125
- MDD US Operations, LLC$119
- Lundbeck LLC$115
- Melinta Therapeutics, LLC$96
- plus $680 from 21 others
What the payments were for
- Food & beverage$1,820100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 23 | $489 |
| Smith+Nephew | 13 | $196 |
| Gilead | 6 | $125 |
| MDD US Operations, LLC | 6 | $119 |
| Lundbeck LLC | 4 | $115 |
| Melinta Therapeutics, LLC | 5 | $96 |
| Merck | 5 | $78 |
| SK Life Science, Inc. | 3 | $77 |
| Biohaven Pharmaceuticals, Inc. | 3 | $70 |
| AbbVie | 3 | $69 |
| Vyera Pharmaceuticals, LLC | 2 | $40 |
| Upsher-smith Laboratories LLC | 2 | $39 |
| Johnson & Johnson | 2 | $34 |
| Lilly USA, LLC | 2 | $31 |
| UCB, Inc. | 1 | $28 |
| Eisai Inc. | 1 | $25 |
| Acera Surgical, Inc. | 1 | $22 |
| Amgen | 1 | $22 |
| Derma Sciences, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Adamas Pharmaceuticals, Inc. | 1 | $14 |
| Theratechnologies Inc. | 1 | $13 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,820 in reported general payments places this provider in the 80th percentile of 194 infectious disease providers in Virginia.
Other infectious disease in Warrenton
- Christopher BettacchiMarion$243K
- Stephen WeinrothFairfax$157K
- William PetriCharlottesville$92K
- Michael IsonFalls Church$88K
- Valerie RiddleBumpass$83K
- Edward OldfieldNorfolk$81K
- William FurlongArlington$68K
- Frederick HaydenCharlottesville$61K
- David WheelerAnnandale$49K
- Amy MathersCharlottesville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.